Shareholders' Equity and Capital Stock (Details) |
9 Months Ended |
---|---|
Sep. 30, 2022
$ / shares
shares
| |
Shareholders' Equity and Capital Stock | |
Outstanding, Beginning Balance | shares | 10,064,024 |
Granted, Options | shares | 175,000 |
Exercised, Options | shares | (640,025) |
Outstanding, Ending Balance | shares | 9,598,999 |
Outstanding, Beginning Balance, Weighted-average Exercise Price | $ / shares | $ 0.68 |
Granted, Weighted-average Exercise Price | $ / shares | 1.74 |
Exercised, Weighted-average Exercise Price | $ / shares | 0.66 |
Outstanding,Ending Balance, Weighted-average Exercise Price | $ / shares | $ 0.64 |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Net number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Weighted average price at which option holders acquired shares when converting their stock options into shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- References No definition available.
|